Table 4.
Clinical management in the previous 12 months
| Diabetes | CHF | |
|---|---|---|
| Mean number of contacts | ||
| Disease specific consultation | 10,17 | 3,71 |
| Blood value monitoring | 4,44 | 3,14 |
| Monitoring in % (N) | ||
| Weight | 94 (17/18) | 43 (3/7) |
| Body Mass Index | 83 (15/18) | 29 (2/7) |
| Systolic blood pressure | 100 (18/18) | 86 (6/7) |
| HbA1C | 83 (15/18) | - |
| Glucose | 78 (14/18) | 57 (4/7) |
| Creatinine | 44 (8/18) | 86 (6/7) |
| Potassium | 39 (7/18) | 71 (5/7) |
| Sodium | 22 (4/18) | 71 (5/7) |
| Total cholesterol | 50 (9/18) | 57 (4/7) |
| HDL | 50 (9/18) | 57 (4/7) |
| LDL | 44 (8/18) | 57 (4/7) |
| Triglycerides | 61 (11/18) | 57 (4/7) |
| Treatment in % (N) | ||
| No treatment | 11 (2/18) | - |
| Diet | 28 (5/18) | - |
| Oral medication | 67 (12/18) | - |
| Insulin | 22 (4/18) | - |
| Antihypertensive | 89 (16/18) | 100 (7/7) |
| Lipid-lowering medication | 78 (14/18) | 57 (4/7) |
| ACE-inhibitor | - | 57 (4/7) |
| Beta blocker | - | 86 (6/7) |
| Furosemide + ACE-inhibitor in comb. w/NSAID | - | 43 (3/7) |